Radiation Oncology/Therapy: Page 54

Lantheus buys rights to PET oncology imaging agent

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings said it has purchased the rights to NTI-1309, a PET oncology imaging agent being developed by Noria Therapeutics.

March 29, 2021

Sun Nuclear launches new facility in the Netherlands

By AuntMinnie.com staff writers

Radiation oncology software developer Sun Nuclear has opened a new facility in Breda, the Netherlands.

March 28, 2021

Pentax goes forward with Hitachi endoscopic US deal

By AuntMinnie.com staff writers

Hoya subsidiary Pentax Medical said that a five-year supply deal with Hitachi announced last July will become effective as of March 31.

March 28, 2021

Varian invests in Israeli microcatheter company

By AuntMinnie.com staff writers

Radiation oncology firm Varian Medical Systems has invested in Israel-based company Bend It Technologies.

March 25, 2021

RF ablation relieves pain for bone cancer patients in 3 days

By Rebekah Moan

Radiofrequency (RF) ablation provides pain relief to patients whose cancer has spread to their bones in as little as three days and the benefits last more than a year, which is longer than the standard radiation treatment.

March 25, 2021

Isotopia to supply MTTI with Lu-177

By AuntMinnie.com staff writers

Isotopia Molecular Imaging announced it has inked a deal to supply biopharmaceutical company Molecular Targeting Technologies (MTTI) with its lutetium-177 (Lu-177) medical isotope for the development of new targeted radiotherapeutics.

March 25, 2021

IBA reports revenue rebound in 2020

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) bounced back with growth of 10.4% in revenues in 2020 after reporting reduced revenues for the first half of the year due to challenges presented by the COVID-19 pandemic.

March 24, 2021

Study evaluates safety of new liver cancer treatment

By AuntMinnie.com staff writers

Boston Scientific announced that its TheraSphere radioembolization treatment is safe and effective for patients with hepatocellular carcinoma, according to a 25 March presentation at the annual meeting of the Society of Interventional Radiology.

March 24, 2021

Novartis touts phase III prostate cancer study results

By AuntMinnie.com staff writers

Novartis is highlighting results from a phase III study that has investigated the efficacy and safety of Lu-177 PSMA-617, a radioligand therapy for patients with prostate-specific membrane antigen-positive metastatic prostate cancer.

March 22, 2021

New radiotracer for neuroendocrine tumors appears safe

By Will Morton

A new radiopharmaceutical based on lutetium-177 being tested for the treatment of neuroendocrine tumors is safe and effective and may allow physicians to cut the radiation dose patients receive by half, according to a study published online March 19 in the Journal of Nuclear Medicine.

March 22, 2021

Sirtex launches study to assess SIR-Spheres for HCC

By AuntMinnie.com staff writers

Radiation oncology firm Sirtex Medical said it has received U.S. Food and Drug Administration approval to begin a multicenter trial to assess its SIR-Spheres yttrium-90 microspheres as a treatment for unresectable advanced hepatocellular carcinoma (HCC).

March 21, 2021

FDA OK's Boston Scientific's TheraSphere Y-90 microspheres

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's TheraSphere yttrium-90 (Y-90) glass microspheres for the treatment of hepatocellular carcinoma.

March 18, 2021

Previous Page

Page 54 of 465

Next Page